NCT07622134

Brief Summary

This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jun 2026Nov 2026

First Submitted

Initial submission to the registry

May 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
13 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2026

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

May 27, 2026

Last Update Submit

June 3, 2026

Conditions

Keywords

Health Literacy ProgramCKD PreventionMedication ManagementNursing InterventionRandomized Controlled TrialThailand

Outcome Measures

Primary Outcomes (2)

  • Health Literacy Levels

    The total score of health literacy regarding chronic kidney disease (CKD) prevention, assessed using a validated Health Literacy Questionnaire. The tool evaluates 6 domains: access, understanding, communication, questioning, decision-making, and practice. Higher scores indicate a higher level of health literacy.

    Baseline, 8 weeks (immediately after intervention), and 12 weeks (follow-up).

  • CKD Prevention Behaviors

    The assessment of self-care behaviors to prevent chronic kidney disease, such as medication adherence, dietary control, and physical activity. Evaluated using the CKD Prevention Behavior Scale.

    Baseline, 8 weeks, and 12 weeks.

Secondary Outcomes (3)

  • Estimated Glomerular Filtration Rate (eGFR)

    Baseline and 12 weeks (follow-up)

  • Serum Creatinine

    Baseline and 12 weeks (follow-up)

  • Urine Albumin-to-Creatinine Ratio (UACR)

    Baseline and 12 weeks (follow-up).

Study Arms (2)

Experimental Group

EXPERIMENTAL

Participants in this group will receive the 8-week Health Literacy Promotion Program (HLP-CKD), which includes educational sessions, skill-building for medication management, and follow-up support.

Behavioral: Health Literacy Promotion Program (HLP-CKD)

Control Group

ACTIVE COMPARATOR

Participants in this group will receive routine nursing care and standard health education provided by the healthcare facility.

Behavioral: Health Literacy Promotion Program (HLP-CKD)

Interventions

An 8-week program consisting of educational sessions, skill-building for medication management, and follow-up support to prevent chronic kidney disease.

Control GroupExperimental Group

Eligibility Criteria

Age55 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 55-74 years diagnosed with non-communicable diseases.
  • Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
  • Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
  • Able to communicate, read, and write in Thai.
  • Willing to participate in the 8-week program and follow-up assessments.

You may not qualify if:

  • Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
  • Having severe cognitive impairment or psychiatric disorders that prevent participation.
  • Having severe complications or being in an unstable clinical condition.
  • Planning to move out of the study area during the 12-week study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Promoting Hospital

Nakhon Pathom, Changwat Nakhon Pathom, 73000, Thailand

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Wanpen Waelveerakup, Dr.P.H.

    Faculty of Nursing, Nakhon Pathom Rajabhat University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wangen Waelveerakup, Dr.P.H.

CONTACT

Wanpen Waelveerakup, Dr.P.H

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor, who is responsible for data collection and evaluation, is blinded to the group assignment to minimize assessment bias.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study is a randomized controlled trial (RCT) with a parallel-group design and a 1:1 allocation ratio. Participants are randomly assigned using computer-generated random numbers. The study procedure is divided into three phases: Baseline assessment (Pre-test) before the intervention. Intervention phase: The experimental group receives an 8-week health literacy promotion program, while the control group receives standard care. Post-intervention evaluation is conducted immediately after the program ends. Follow-up phase: A follow-up assessment is performed at 12 weeks to evaluate the long-term effectiveness of the program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 27, 2026

First Posted

June 2, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

November 15, 2026

Last Updated

June 4, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to protect the privacy and confidentiality of the participants, in accordance with the informed consent and institutional ethical guidelines.

Locations